Treatment options and outcomes for glioblastoma in the elderly patient

por Arvold, Nils D, Reardon, David A
Publicado 2014

Current available therapies and future directions in the treatment of malignant gliomas

por Desjardins, Annick, Reardon, David A, Vredenburgh, James J
Publicado 2009

Efficacy and safety of immune checkpoint blockade for brain metastases

por Harary, Maya, Reardon, David A, Iorgulescu, J Bryan
Publicado 2019

Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy – Detecting Illusive Disease, Defining Response

por Huang, Raymond Y., Neagu, Martha R., Reardon, David A., Wen, Patrick Y.
Publicado 2015

A dose escalation trial for the combination of erlotinib and sirolimus for recurrent malignant gliomas

por Nghiemphu, Phioanh Leia, Lai, Albert, Green, Richard M., Reardon, David A., Cloughesy, Timothy
Publicado 2012

Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials

por Han, Kelong, Ren, Melanie, Wick, Wolfgang, Abrey, Lauren, Das, Asha, Jin, Jin, Reardon, David A.
Publicado 2014

Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma

por Han, Kelong, Ren, Melanie, Wick, Wolfgang, Abrey, Lauren, Das, Asha, Jin, Jin, Reardon, David A.
Publicado 2015

Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: A case report

por Alshami, Jad, Guiot, Marie-Christine, Owen, Scott, Kavan, Petr, Gibson, Neil, Solca, Flavio, Cseh, Agnieszka, Reardon, David A., Muanza, Thierry
Publicado 2015

Blood-brain barrier disruption and delivery of irinotecan in a rat model using a clinical transcranial MRI-guided focused ultrasound system

por McDannold, Nathan, Zhang, Yongzhi, Supko, Jeffrey G., Power, Chanikarn, Sun, Tao, Vykhodtseva, Natalia, Golby, Alexandra J., Reardon, David A.
Publicado 2020

Acoustic feedback enables safe and reliable carboplatin delivery across the blood-brain barrier with a clinical focused ultrasound system and improves survival in a rat glioma mode...

por McDannold, Nathan, Zhang, Yongzhi, Supko, Jeffrey G., Power, Chanikarn, Sun, Tao, Peng, Chengueng, Vykhodtseva, Natalia, Golby, Alexandra J, Reardon, David A.
Publicado 2019

Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143

por Omuro, Antonio, Reardon, David A, Sampson, John H, Baehring, Joachim, Sahebjam, Solmaz, Cloughesy, Timothy F, Chalamandaris, Alexandros-Georgios, Potter, Von, Butowski, Nicholas, Lim, Michael
Publicado 2022

Modeling tumor immunity of mouse glioblastoma by exhausted CD8(+) T cells

por Nakashima, Hiroshi, Alayo, Quazim A., Penaloza-MacMaster, Pablo, Freeman, Gordon J., Kuchroo, Vijay K., Reardon, David A., Fernandez, Soledad, Caligiuri, Michael, Chiocca, E. Antonio
Publicado 2018

Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib

por Owen, Scott, Alken, Scheryll, Alshami, Jad, Guiot, Marie-Christine, Kavan, Petr, Reardon, David A, Muanza, Thierry, Gibson, Neil, Pemberton, Karine, Solca, Flavio, Cseh, Agnieszka, Saran, Frank
Publicado 2022

An expanded role for surgery in grade 3 1p/19q co-deleted oligodendroglioma

por Gupta, Saksham, Nawabi, Noah L, Emani, Siva, Medeiros, Lila, Bernstock, Joshua D, Duvall, Julia, Ng, Patrick, Smith, Timothy R, Wen, Patrick Y, Reardon, David A, Arnaout, Omar
Publicado 2023

A Novel Method for Volumetric MRI Response Assessment of Enhancing Brain Tumors

por Kanaly, Charles W., Ding, Dale, Mehta, Ankit I., Waller, Anthony F., Crocker, Ian, Desjardins, Annick, Reardon, David A., Friedman, Allan H., Bigner, Darell D., Sampson, John H.
Publicado 2011

An Online Calculator for the Prediction of Survival in Glioblastoma Patients Using Classical Statistics and Machine Learning

por Senders, Joeky T, Staples, Patrick, Mehrtash, Alireza, Cote, David J, Taphoorn, Martin J B, Reardon, David A, Gormley, William B, Smith, Timothy R, Broekman, Marike L, Arnaout, Omar
Publicado 2020

Glioma genetic profiles associated with electrophysiologic hyperexcitability

por Tobochnik, Steven, Dorotan, Maria Kristina C., Ghosh, Hia S., Lapinskas, Emily, Vogelzang, Jayne, Reardon, David A., Ligon, Keith L., Bi, Wenya Linda, Smirnakis, Stelios M., Lee, Jong Woo
Publicado 2023

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma

por Lou, Emil, Peters, Katherine B, Sumrall, Ashley L, Desjardins, Annick, Reardon, David A, Lipp, Eric S, Herndon, James E, Coan, April, Bailey, Leighann, Turner, Scott, Friedman, Henry S, Vredenburgh, James J
Publicado 2013

PARP inhibition utilized in combination therapy with Olaparib‐Temozolomide to achieve disease stabilization in a rare case of BRCA1‐mutant, metastatic myxopapillary ependymoma

por Mahalingam, Preethika, Smith, Sam, Lopez, Juanita, Sharma, Rajaei K, Millard, Thomas, Thway, Khin, Fisher, Cyril, Reardon, David A, Jones, Robin, Nicholson, Andrew G, Cunningham, David, Welsh, Liam, Sharma, Bhupinder
Publicado 2023

Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy

por Cloughesy, Timothy F, Drappatz, Jan, de Groot, John, Prados, Michael D, Reardon, David A, Schiff, David, Chamberlain, Marc, Mikkelsen, Tom, Desjardins, Annick, Ping, Jerry, Holland, Jaymes, Weitzman, Ron, Wen, Patrick Y
Publicado 2018